Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-01-03 @ 1:00 PM
Study NCT ID:
NCT04688151
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-22
First Post:
2020-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma.
Sponsor:
Organization: